Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
Visionix Unveils VX 610 Fundus Camera for DR Screening
Visionix USA has introduced the VX 610, a non-mydriatic automated fundus camera designed to improve retinal imaging and diabetic retinopathy screening. The VX 610 features auto alignment, auto focus, and auto capture, allowing for consistent, high-quality imaging with minimal user…
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
Oculus has unveiled the Pentacam Cornea OCT, an innovative device that integrates Scheimpflug imaging with the world’s first pericentric OCT scanning system. This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the cornea in just one…
LENSAR Receives EU Certification for ALLY®
First EU ALLY Commercial Installation Expected in August 2024 ORLANDO, Fla.—LENSAR, Inc. (Nasdaq: LNSR), a global medical technology company specializing in advanced laser solutions for cataract treatment, announced that the ALLY Adaptive Cataract Treatment System has achieved certification under the…
Top 5 Misconceptions About LASIK Surgery
LASIK surgery has revolutionized the field of vision correction, providing millions of people with clearer vision and freedom from glasses or contact lenses. However, myths and misconceptions surrounding LASIK surgery persist, causing uncertainty and misinformation. Let’s debunk the top 5…
What’s in Store for ESCRS 2024? Workshops, Labs, and More
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for its 42nd Annual Congress with a rich lineup of initiatives designed to enhance learning, foster collaboration, and celebrate advancements in ophthalmology. This year’s event will feature a…
Exclusive: Key Events at ESCRS 2024
The 42nd of the European Society of Cataract and Refractive Surgeons (ESCRS) is poised to offer a dynamic array of events and initiatives in 2024, featuring a mix of educational programs, commemorative milestones, and new insights into key areas of…
ViaLase Laser Granted CE Mark Approval for Glaucoma
ViaLase has received CE Mark approval in the European Union for its ViaLase laser, designed to treat adult patients with primary open-angle glaucoma. The ViaLase laser employs the precision of a femtosecond laser combined with micron-level image guidance to perform…
Spryte’s nOCT Tech Gets FDA Breakthrough Device Designation
Spryte Medical announced that its Neuro Optical Coherence Tomography (nOCT) technology has been awarded Breakthrough Device Designation by the FDA. This designation highlights the potential of nOCT to revolutionize neurointervention and cerebrovascular treatment. FDA Breakthrough Device Designation The FDA’s Breakthrough…
Eyenovia and Senju Collaborate on Novel Dry Eye Treatment
Eyenovia, a leading ophthalmic company, announced a collaboration agreement with Senju Pharmaceutical to develop SJP-0035, a corneal epithelial wound healing candidate, using Eyenovia’s Optejet® dispensing technology for chronic dry eye disease treatment. Strategic Collaboration for Innovative Treatment Under the agreement,…
Johnson & Johnson Invests in Start-Up TECLens
Johnson & Johnson has recently finalized a strategic investment in TECLens, a pioneering start-up focused on advancing nonincisional refractive correction technology through corneal cross-linking (CXL). The investment, part of a co-leading effort in TECLens’ Series A funding round, underscores Johnson…